Screenshot 2014-12-27 17.08.53BRCA1 and BRCA2 mutation carriers can reduce their risk of ovarian, Fallopian and peritoneal cancer by 80% by removing both ovaries and tubes. This has not been the understanding to date, but recent data presented at ASCO confirms this staggering risk reduction of the related cancers. Furthermore, there is a 77% reduction in risk of death from all causes.

Continue Reading…